Epidemiology of myosteatosis

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 13, Issue 3, 2010, Pages 260-264

  Miljkovic, Iva ^a   Zmuda, Joseph M ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aging; Diabetes; Fat; Insulin resistance; Intermuscular fat; Intramyocellular fat; Myosteatosis; Skeletal muscle

Indexed keywords

GLUCOSE; INSULIN;

AGING; BLOOD FLOW; CYTOKINE RELEASE; DISEASE ASSOCIATION; HUMAN; HYPOTHESIS; INSULIN RESISTANCE; MYOPATHY; MYOSTEATOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; RISK FACTOR; SKELETAL MUSCLE; STEATOSIS; WEIGHT CHANGE; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM; MUSCLE DISEASE;

ADIPOSITY; DIABETES MELLITUS, TYPE 2; INSULIN RESISTANCE; MUSCLE, SKELETAL; MUSCULAR DISEASES; OBESITY; RISK FACTORS;

EID: 77951464175     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328337d826     Document Type: Review

References (36)

1. Kuk JL, Saunders TJ, Davidson LE, et al. Age-related changes in total and regional fat distribution. Ageing Res Rev 2009; 8:339-348.
2. Larson-Meyer DE, Smith SR, Heilbronn LK, et al. Muscle-associated triglyceride measured by computed tomography and magnetic resonance spectroscopy. Obesity (Silver Spring) 2006; 14:73-87.
3. Goodpaster BH, Kelley DE, Thaete FL, et al. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 2000; 89:104-110.
4. Sinanan ACM, Buxton PG, Lewis MP. Muscling in on stem cells. Biol Cell 2006; 98:203-214.
5. Delmonico MJ, Harris TB, Visser M, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 2009;90:1579-1585.
6. Kelley DE, Mokan M, Simoneau JA, et al. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993; 92:91-98.
7. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414:799-806.
8. Goodpaster BH, He J, Watkins S, et al. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001; 86:5755-5761.
9. Brehm A, KrssakM, Schmid AI, et al. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 2006; 55:136-140.
10. Perseghin G, Scifo P, De Cobelli F, et al. Intramyocellulartriglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999; 48:1600-1606.
11. Godoy-Matos AF, Bahia LR, Domingues RC, et al. Adiponectin is related to intramyocellular lipid content in non-diabetic adults. J Endocrinol Invest 2009 [Epub ahead of print]. doi:10.3275/6474.
12. Kantartzis K, Staiger H, Machann J, et al. Adiponectin oligomers and ectopic fat in liver and skeletal muscle in humans. Obesity (Silver Spring) 2009; 17:390-392.
13. Wiecek A, Adamczak M, Chudek J. Adiponectin: an adipokine with unique metabolic properties. Nephrol Dial Transplant 2007; 22:981-988.
14. Goodpaster BH, Krishnaswami S, Resnick H, et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003; 26: 372-379.
15. Miljkovic-Gacic I, Gordon CL, Goodpaster BH, et al. Adipose tissue infiltration in skeletal muscle: age patterns and association with diabetes among men of African ancestry. Am J Clin Nutr 2008; 87:1590-1595.
16. Miljkovic I, Cauley JA, Petit MA, et al. Greater adipose tissue infiltration in skeletal muscle among older men of African ancestry. J Clin Endocrinol Metab 2009; 94:2735-2742.
17. Boettcher M, Machann J, Stefan N, et al. Intermuscular adipose tissue (IMAT): association with other adipose tissue compartments and insulin sensitivity. J Magn Reson Imaging 2009; 29:1340-1345.
18. Zoico E, Rossi A, Di Francesco V, et al. Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level. J Gerontol A Biol Sci Med Sci 2010; 65A:295-299.
19. Gallagher D, Kelley DE, Yim JE, et al. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009; 89:807-814.
20. Hilton TN, Tuttle LJ, Bohnert KL, et al. Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys Ther 2008; 88:1336-1344.
21. Beasley LE, Koster A, Newman AB, et al. Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity (Silver Spring) 2009; 17:1062-1069.
22. Coen PM, Dube JJ, Amati F, et al. Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 2010; 59:80-88.
23. De Feyter HM, Lenaers E, Houten SM, et al. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity through out the pathogenesis of type 2 diabetes. FASEB J 2008; 22:3947-3955.
24. Gan SK, Samaras K, Thompson CH, et al. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes 2002; 51:3163-3169.
25. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med 2006; 119 (5 Suppl 1):S10-S16.
26. Timmers S, Schrauwen P, de Vogel J. Muscular diacylglycerol metabolism and insulin resistance. Physiol Behav 2008; 94:242-251.
27. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307:384-387.
28. Vettor R, Milan G, Franzin C, et al. The origin of intermuscular adipose tissue and its pathophysiological implications. Am J Physiol Endocrinol Metab 2009; 60:987-998.
29. Lee DE, KehlenbrinkS, LeeH, et al. Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab 2009; 296:E1210-E1229.
30. Goodpaster BH, Theriault R, Watkins SC, et al. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 2000; 49:467-472. (Pubitemid 30196572)
31. Malenfant P, Tremblay A, Doucet E, et al. Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training. Am J Physiol Endocrinol Metab 2001; 280:E632-E639. (Pubitemid 32466863)
32. Roden M. Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int J Obes (Lond) 2005; 29 (Suppl 2):S111-S115.
33. Moro C, Bajpeyi S, Smith SR. Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity. Am J Physiol Endocrinol Metab 2008; 294:E203-E213. (Pubitemid 351231448)
34. Le KA, Ith M, Kreis R, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009; 89:1760-1765.
35. Shortreed KE, Krause MP, Huang JH, et al. Muscle-specific adaptations, impaired oxidative capacity and maintenance of contractile function characterize diet-induced obese mouse skeletal muscle. PLoS One 2009; 4: e7293.
36. Brancati FL, Kao WH, Folsom AR, et al. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000; 283:2253-2259.